Understanding the genetic basis of these conditions is essential for developingeffective treatments and interventions for managing cardiac arrhythmias and SCD.Several studies [9, 11, 12] have investigated the role and mechanisms of ANK2 genevariants in cardiovascular diseases. This evidence concerns the gene ANK2 and chronic obstructive pulmonary disease.